TMCnet News
Hot Stock: AVANIR Pharmaceuticals, Shares Drop 6.5% (AVNR)Feb 07, 2013 (SmarTrend(R) Spotlight via COMTEX) -- AVANIR Pharmaceuticals (NASDAQ:AVNR) is one of today's worst performing low-priced stocks, down 6.5% to $2.88 on 1.6x average daily volume. Thus far today, AVANIR Pharmaceuticals has traded 1.9 million shares, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-6.5% to the Dow's -0.8%) and underperformed the S&P 500 (-6.5% to the S&P's -0.6%) during today's trading. There is potential upside of 131.5% for shares of AVANIR Pharmaceuticals based on a current price of $2.88 and an average consensus analyst price target of $6.67. AVANIR Pharmaceuticals shares should encounter resistance at the 200-day moving average (MA) of $3.02 and support at the 50-day MA of $2.83. AVANIR Pharmaceuticals share prices have moved between a 52-week high of $4.05 and a 52-week low of $2.07 and are now trading 39% above that low price at $2.88 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.4% while the 200-day MA has remained constant. AVANIR Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases. SmarTrend recommended that subscribers consider buying shares of AVANIR Pharmaceuticals on January 3rd, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $2.86. Since that recommendation, shares of AVANIR Pharmaceuticals have risen 7.7%. We continue to monitor AVNR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |